Vision & Reality – Capgemini's annual thought leadership publication for the Life Sciences industry
Vision and Reality is a series of annual thought leadership publications on the implications on life sciences companies of key trends and changes that impact the industry. It is based on global research covering the perspectives of senior executives within major pharmaceutical, biotech and medical device companies. It also captures the insights of leading industry experts and the perspectives of payers and patients. Vision and Reality provides a unique point of view on upcoming industry challenges and provides strategies and methods for dealing with them.
Every issue of Vision and Reality focuses on a research topic that is both timely and pressing for the industry. Previous publications covered:
- V&R 6 th edition: From Market to Discovery and back – The Value of Early Commercialization
- V&R 5 th edition: Thriving in the Healthcare Environment – Better Health Outcomes through Collaboration
- V&R 4 th edition: Increasing the lifetime value of pharmaceutical products
All final results of the study will be available later this year on the vision & reality portal ( www.visionandreality.com ). You can also order a copy .We would like to thank you in advance for your participation. We hope the materials provided will be of interest. Should you require any additional information, please contact us at the addresses listed below. We will be happy to answer your questions.
 |
Vision & Reality 6th Edition:“
From Market to Discovery and back – The Value of Early Commercialization
” |
|
 |
Vision & Reality Research 2005:“Thriving in the Healthcare Environment – Better Health Outcomes through Collaboration” |
|
 |
Vision & Reality Research 2004:“Increasing the lifetime value of pharmaceutical products” |
